Serum CK19-2G2 levels in breast cancer patients.
- Yanan Kong (384071)
- Junye Wang (384072)
- Wanli Liu (384073)
- Qiaolun Chen (384074)
- Juan Yang (384075)
- Weidong Wei (384076)
- Mingqing Wu (384077)
- Lu Yang (30847)
- Xinhua Xie (384078)
- Ning Lv (384079)
- Jiaoli Guo (384080)
- Laisheng Li (384081)
- Jie Gao (10266)
- Xiaoming Xie (181426)
- Shuqin Dai (384082)
Publication date
March 2013
DOIAbstract
<p>(<b>A</b>) The Mean of serum CK19-2G2 levels in healthy, benign, BC group. Serum CK19-2G2 levels in breast cancer patients are higher than those in the healthy and benign controls respectively.(BC <i>vs Benign, P</i><0.001; BC <i>vs Normal, P</i><0.001) (Mann-Whitney <i>U</i> test).Error bars are referring to SE(Standard Error). (<b>B</b>) The Mean of serum CK19-2G2 levels in breast cancer patients with LuminalA/B, HER2-enriched and Triple negative type. There was no difference among the three groups.Error bars are referring to SE(Standard Error).</p
Add to ORKG